Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ralph

Showing results (121-130 of 218) with videos related to

Pageof 22
Sort By:
Pediatrics|December 17, 2004
Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremiaAnne Marie Valente, Rajiv Jain, Mark Scheurer, et al.
BMJ (Clinical Research Ed.)|May 5, 2011
Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after studyMartin H Thornhill, Mark J Dayer, Jamie M Forde, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureusEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Perioperative Medicine (London, England)|June 18, 2016
A randomized, double-blind, placebo controlled safety, tolerability, and pharmacokinetic dose escalation study of a gentamicin vancomycin gel in patients undergoing colorectal surgeryElliott Bennett-Guerrero, Harold S Minkowitz, Alvaro M Segura-Vasi, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 6, 2007
Correlation between fundamental binding forces and clinical prognosis of Staphylococcus aureus infections of medical implantsRuchirej Yongsunthon, Vance G Fowler, Brian H Lower, et al.
Current Infectious Disease Reports|July 10, 2007
Medical treatment of endocarditisElias Abrutyn, Christopher H Cabell, Vance G Fowler, et al.
International Journal of Antimicrobial Agents|February 5, 2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trialsG Ralph Corey, Mark H Wilcox, Jesus Gonzalez, et al.
Diagnostic Microbiology and Infectious Disease|November 7, 2017
The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogensDavid B Huang, Leonard R Duncan, Robert K Flamm, et al.
American Heart Journal|May 17, 2011
Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: an academic model for countering the epidemicGerald S Bloomfield, Sylvester Kimaiyo, E Jane Carter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infectionG Ralph Corey, Mark Wilcox, George H Talbot, et al.
Pageof 22

Showing results (121-130 of 218) with videos related to

Sort By:
Pageof 22
Pediatrics|December 17, 2004
Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremiaAnne Marie Valente, Rajiv Jain, Mark Scheurer, et al.
BMJ (Clinical Research Ed.)|May 5, 2011
Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after studyMartin H Thornhill, Mark J Dayer, Jamie M Forde, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureusEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Perioperative Medicine (London, England)|June 18, 2016
A randomized, double-blind, placebo controlled safety, tolerability, and pharmacokinetic dose escalation study of a gentamicin vancomycin gel in patients undergoing colorectal surgeryElliott Bennett-Guerrero, Harold S Minkowitz, Alvaro M Segura-Vasi, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 6, 2007
Correlation between fundamental binding forces and clinical prognosis of Staphylococcus aureus infections of medical implantsRuchirej Yongsunthon, Vance G Fowler, Brian H Lower, et al.
Current Infectious Disease Reports|July 10, 2007
Medical treatment of endocarditisElias Abrutyn, Christopher H Cabell, Vance G Fowler, et al.
International Journal of Antimicrobial Agents|February 5, 2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trialsG Ralph Corey, Mark H Wilcox, Jesus Gonzalez, et al.
Diagnostic Microbiology and Infectious Disease|November 7, 2017
The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogensDavid B Huang, Leonard R Duncan, Robert K Flamm, et al.
American Heart Journal|May 17, 2011
Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: an academic model for countering the epidemicGerald S Bloomfield, Sylvester Kimaiyo, E Jane Carter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infectionG Ralph Corey, Mark Wilcox, George H Talbot, et al.
Pageof 22